The diagnosis of LCNEC is based on recognition of both neuroendocrine morphology and the immunohistochemical demonstration of specific neuroendocrine markers, such as chromogranin, synaptophysin, and neural cell adhesion molecule, also known as CD56 [9]. Here, CHL1 is linked to large cell neuroendocrine carcinoma.